Gerry Brunk - Profile and Investment Details

Investor Profile

Gerry Brunk is a Venture Capital, Private Equity Firm, Micro VC based in Boston, Massachusetts, United States with a diverse investment portfolio that includes companies such as Cardiac Dimensions, Exact Imaging, Notch Therapeutics, Social Change Rewards, OsteoQC Inc, Edesa Biotech, Aurinia Pharmaceuticals, KalGene Pharmaceuticals, AmacaThera, Opsens, Thrasos, Iterion Therapeutics, Celtaxsys, Vendorlink.ca, Bardy Diagnostics, Pediapharm, EndogenexOsteopathy Quebec, IMV, XyloCor Therapeutics, Corvia Medical, Spinal Kinetics, Engage Therapeutics, Forbius, Sound Blade Medical Inc., Cyrano Therapeutics, Endotronix, First Aid Shot Therapy, Usystems, Zymeworks, G1 Therapeutics, Vascular Pharmaceuticals, HistoSonics, HistoSonics, Inc., BAROnova, Gladius Pharmaceuticals, Bright Angel Therapeutics, Antios Therapeutics, Satsuma Pharmaceuticals, IMV Inc, KisoJi Biotechnology, Argos Therapeutics, enGene, . Over time, Gerry Brunk has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Gerry Brunk is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Women Founded, Biotechnology, Lending, Developer Tools, Medical, Big Data, Therapeutics, Media and Entertainment, Pharmaceuticals may find it worthwhile to explore potential connections with Gerry Brunk, as their portfolio suggests a familiarity and interest in this area.

Understanding Gerry Brunk’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.